Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Bovine collagen + lidocaine** refers to a combination injectable or topical product containing purified bovine (cow-derived) collagen as a structural biopolymer and lidocaine as a local anesthetic. **Bovine collagen** serves as a temporary scaffold for tissue augmentation (especially for soft tissue/facial wrinkles, scars, or wound healing) by providing structural support and stimulating endogenous collagen production, while **lidocaine** blocks voltage-gated sodium channels to provide local anesthesia and reduce pain during or after administration. This combination is primarily used in aesthetic medicine for soft-tissue augmentation (like nasolabial fold correction) and sometimes for wound or ulcer management. Bovine collagen products generally require pre-administration skin allergy screening, as a minority of patients (~3%) will show hypersensitivity[6]. Lidocaine is added specifically to improve patient comfort during administration[1][6]. This combination is distinct from porcine or marine collagen combinations, which have different immunogenicity profiles and approval statuses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bovine collagen + lidocaine.